TABLE 3.

Impact of comorbid conditions on survival in women who were diagnosed with endometrial cancer

Variable	White women			Black women			P interaction
	Hazard ratioa	95% confidence interval	P value	Hazard ratioa	95% confidence interval	P value
Death from any cause
Diabetes mellitus	1.63	1.13–2.35	.009	1.17	0.80–1.71	.429	.302
Hypertension	0.96	0.70–1.32	.817	0.52	0.34–0.79	.003	.008
Obesity (body mass index, ≥30 kg/m2)	1.04	0.75–1.43	.820	1.04	0.69–1.56	.865	.670
Morbid obesity (body mass index, ≥40 kg/m2)	1.33	0.86–2.06	.198	1.07	0.70–1.63	.771	.901
Charlson comorbidity score							.991
1	1.89	1.24–2.90	.003	1.07	0.66–1.72	.795
≥2	1.71	1.17–2.50	.006	2.28	1.46–3.56	< .001
Death from endometrial cancer
Diabetes mellitus	1.00	0.40–2.49	.999	0.71	0.36–1.37	.302	.978
Hypertension	0.47	0.23–0.98	.044	0.35	0.19–0.67	.001	.740
Obesity (body mass index, ≥30 kg/m2)	0.89	0.44–1.79	.739	0.81	0.44–1.51	.510	.723
Morbid obesity (body mass index, ≥40 kg/m2)	0.72	0.24–2.15	.557	1.04	0.53–2.02	.913	.760
Charlson comorbidity score							.312
1	2.74	1.16–6.48	.022	1.10	0.51–2.36	.806
≥2	0.92	0.35–2.41	.864	1.97	0.98–3.98	.059

^aAdjusted for year and age at diagnosis, Federation of International Gynecologists and Obstetricians stage, grade, histologic type, receipt of surgery, chemotherapy, and radiation therapy.

Ruterbusch. Race, comorbidities, and endometrial cancer survival. Am J Obstet Gynecol 2014.